Aeroflex Incorporated Receives $5.0 Million Order for High-Reliability Semiconductor Products.PLAINVIEW, N.Y. -- Aeroflex Incorporated (Nasdaq Symbol: ARXX), announced today that it has received a $5 million order for High-Reliability ASICs (Application Specific Integrated Circuits Integrated circuits Miniature electronic circuits produced within and upon a single semiconductor crystal, usually silicon. Integrated circuits range in complexity from simple logic circuits and amplifiers, about 1/20 in. (1. ) and Standard Data Communication Products. The products will be used for a major military subcontractor's jet engine, flight and cabin environmental controls. Initial deliveries will commence this quarter and are expected to be completed by January 2010. "We are very pleased to have received this strategic award to support this prominent military subcontractor One who takes a portion of a contract from the principal contractor or from another subcontractor. When an individual or a company is involved in a large-scale project, a contractor is often hired to see that the work is done. ," said John Buyko, President, Aeroflex Microelectronic The miniaturization of electronic circuits. See chip. Solutions. "The order is part of $15M in awards from this customer in the past sixteen months. Aeroflex has a long history of supplying High-Reliability and radiation-hardened ASICs and integrated circuits to the aerospace, satellite and defense community. "Aeroflex provides products specifically designed for military and commercial avionic a·vi·on·ics n. 1. (used with a sing. verb) The science and technology of electronics and the development of electronic devices as applied to aeronautics and astronautics: applications such as high-temperature engines, environmental cabin control, and data communications data communications, application of telecommunications technology to the problem of transmitting data, especially to, from, or between computers. In popular usage, it is said that data communications make it possible for one computer to "talk" with another. ," continued Mr. Buyko. "As a fab-independent supplier, we offer customers the benefits of our multiple foundry partners, coupled with state-of-the-art design and technology processes." About Aeroflex Aeroflex Incorporated is a leading global provider of high technology solutions to the aerospace, defense and broadband communications markets. The Company's diverse technologies allow it to design, develop, manufacture and market a broad range of test, measurement and microelectronic products. The Company's common stock trades on the Nasdaq National Market System under the symbol ARXX and is included in the S&P SmallCap 600 index. Additional information concerning Aeroflex Incorporated can be found on the Company's Web site: www.aeroflex.com. All statements other than statements of historical fact included in this press release regarding Aeroflex's financial position, business outlook, business strategy and plans and objectives of its management for future operations are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . When used in this press release, words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to Aeroflex or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of Aeroflex's management, as well as assumptions made by and information currently available to its management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to, competitive factors and pricing pressures, the integration of acquired businesses, changes in legal and regulatory requirements Regulatory requirements are part of the process of drug discovery and drug development. Regulatory requirements describe what is necessary for a new drug to be approved for marketing in any particular country. , technological change or difficulties, product development risks, commercialization difficulties, general economic conditions, and other risk factors disclosed in Aeroflex's most recently filed Form 10-Q Form 10-Q See 10-Q. . Such statements reflect the current views of management with respect to the future and are subject to these and other risks, uncertainties and assumptions relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc Aeroflex's financial condition, results of operations, growth strategy and liquidity. Aeroflex does not undertake any obligation to update such forward-looking statements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion